Quiz-summary
0 of 1 questions completed
Questions:
- 1
Information
Presented by Theresa Chan, M.D. and prepared by Jeffrey Seibel, M.D. Ph.D.
Case 6: 67-year-old male with hematuria and a biopsy of the prostatic urethra.
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading...
You must sign in or sign up to start the quiz.
You have to finish following quiz, to start this quiz:
Results
Time has elapsed
Categories
- Not categorized 0%
- 1
- Answered
- Review
-
Question 1 of 1
1. Question
Week 83: Case 6
67-year-old male with hematuria and a biopsy of the prostatic urethra./images/032502case6a.jpg
/images/032502case6b.jpg
/images/032502case6c.jpg
/images/032502case6d.jpgCorrect
Answer: Prostatic duct adenocarcinoma
Histology: The lesion consists of a papillary mass within the prostatic urethra. The papillae are lined by glandular cells, which range from a single layer to being pseudo-stratified. In areas, tall columnar epithelium can be seen. The cells have abundant eosinophilic cytoplasm. The nuclei show significant atypia and are enlarged with prominent nucleoli.
Discussion: Prostatic duct adenocarcinoma can be differentiated from high-grade prostatic intraepithelial neoplasia by its architectural complexity, growth along true fibrovascular cores, and the degree of nuclear atypia. In this particular case, the entire tumor shows a papillary growth pattern, which raises the possibility of a high-grade papillary urothelial carcinoma. This lesion, however, has cells with true glandular differentiation with abundant eosinophilic cytoplasm and areas of tall columnar epithelium. This argues against a papillary urothelial carcinoma. Prostatic urethral polyps form polypoid urethral masses lined by completely benign prostatic secretory cells and are associated with benign appearing prostate glands.
Prostatic duct adenocarcinoma is an aggressive tumor that may present as a periurethral mass. There are two architectural patterns that may be seen, one of which is the papillary form seen in this case. The other shows cribriform nests of cancer. These tumors may also arise in more peripheral prostatic ducts and therefore can be sampled on prostate needle biopsies. Prostatic duct adenocarcinomas behave more aggressively than ordinary acinar adenocarcinomas, with more advanced pathologic stage at radical prostatectomy and having a higher recurrence rate.
Incorrect
Answer: Prostatic duct adenocarcinoma
Histology: The lesion consists of a papillary mass within the prostatic urethra. The papillae are lined by glandular cells, which range from a single layer to being pseudo-stratified. In areas, tall columnar epithelium can be seen. The cells have abundant eosinophilic cytoplasm. The nuclei show significant atypia and are enlarged with prominent nucleoli.
Discussion: Prostatic duct adenocarcinoma can be differentiated from high-grade prostatic intraepithelial neoplasia by its architectural complexity, growth along true fibrovascular cores, and the degree of nuclear atypia. In this particular case, the entire tumor shows a papillary growth pattern, which raises the possibility of a high-grade papillary urothelial carcinoma. This lesion, however, has cells with true glandular differentiation with abundant eosinophilic cytoplasm and areas of tall columnar epithelium. This argues against a papillary urothelial carcinoma. Prostatic urethral polyps form polypoid urethral masses lined by completely benign prostatic secretory cells and are associated with benign appearing prostate glands.
Prostatic duct adenocarcinoma is an aggressive tumor that may present as a periurethral mass. There are two architectural patterns that may be seen, one of which is the papillary form seen in this case. The other shows cribriform nests of cancer. These tumors may also arise in more peripheral prostatic ducts and therefore can be sampled on prostate needle biopsies. Prostatic duct adenocarcinomas behave more aggressively than ordinary acinar adenocarcinomas, with more advanced pathologic stage at radical prostatectomy and having a higher recurrence rate.